Muscarinic agonists in Alzheimer's disease
- 1 February 1997
- journal article
- Published by Elsevier in Life Sciences
- Vol. 60 (13-14) , 993-998
- https://doi.org/10.1016/s0024-3205(97)00039-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cognitive functions affected by scopolamine in alzheimer's disease and normal agingDrug Development Research, 1988
- Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkeyJournal of Comparative Neurology, 1983
- Alzheimer's diseaseJournal of the Neurological Sciences, 1982
- Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalisAnnals of Neurology, 1981
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- Physostigmine: Improvement of Long-Term Memory Processes in Normal HumansScience, 1978
- Human Serial Learning: Enhancement with Arecholine and Choline Impairment with ScopolamineScience, 1978
- Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brainsBrain Research, 1977
- NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIAThe Lancet, 1977
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976